JACOBS LEVY EQUITY MANAGEMENT, INC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 884414 FLORHAM PARK, NJ

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$159,939,880

-$5,528,702 QoQ

Shares Held

256,503

+19.8% QoQ

Ownership

0.249%

of shares outstanding

% of Portfolio

0.58%

of 13F equity value

Holder Rank

#54

of 1,322 holders

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 72% Shared 0% None 28%

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. REGN ranks #1 (21.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	256,503	$159,939,880
2	RARE	Ultragenyx Pharmaceutical Inc.	2,939,719	$98,157,217
3	INCY	Incyte Corp	731,774	$82,953,900
4	CORT	Corcept Therapeutics Inc	695,532	$60,476,507
5	HALO	Halozyme Therapeutics, Inc.	322,377	$25,232,447
6	EXEL	Exelixis, Inc.	415,650	$22,615,516
7	AUPH	Aurinia Pharmaceuticals Inc.	1,231,516	$20,898,826
8	ALNY	Alnylam Pharmaceuticals, Inc.	60,986	$18,358,615

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$159,939,880	256,503	+19.8%	Shares	Sole	2026-08-14
2026-03-31	$165,468,582	214,160	-19.2%	Shares	Sole	2026-05-15
2025-12-31	$204,538,603	264,991	-8.0%	Shares	Sole	2026-02-13
2025-09-30	$161,866,849	287,881	+22.9%	Shares	Sole	2025-11-17
2025-06-30	$122,990,175	234,267	+31261.0%	Shares	Sole	2025-08-14
2025-03-31	$473,769	747	-11.8%	Shares	Sole	2025-05-15
2024-12-31	$603,343	847	-96.4%	Shares	Sole	2025-02-14
2024-09-30	$24,799,802	23,591	+76.3%	Shares	Sole	2024-11-14
2024-06-30	$14,060,679	13,378	+3595.6%	Shares	Sole	2024-08-14
2024-03-31	$348,421	362	+1.7%	Shares	Sole	2024-05-15
2023-12-31	$312,671	356	+1.7%	Shares	Sole	2024-02-14
2021-12-31	$221,032	350	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.